Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis
Sponsor: Arbelaez, Ana Maria
Listed as NCT00763412, this NA trial focuses on Cystic Fibrosis Related Diabetes and Pancreatic Insufficiency and remains completed. Sponsored by Arbelaez, Ana Maria, it has been updated 10 times since 2006, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jul 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Jul 2017 [monthly]
Completed NA
First recorded
Nov 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Arbelaez, Ana Maria
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institutes of Health (NIH)
- Novo Nordisk A/S
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .